In the development, progression and treatment of depression, an increasing number of researchers have focused on the association between CRP levels and depressive symptoms [including major depressive disorder (MDD) and treatment-resistant depression (TRD)] (Orsolini et al., 2022). This evidence concerns the gene CRP and depressive disorder.